NEW YORK (AP) — Botox maker Allergan Plc. is buying Kythera Biopharmaceuticals for about $2.1 billion, adding a drug that destroys fat cells and eliminates the cosmetic condition referred to as ...
(And if you follow our advice, no one will ever know you got it.) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results